1
Home
Companies

Everest Medicines

Everest Medicines
Leadership team

Mr. Wei Fu (Exec. Chairman)

Mr. Yongqing Luo (CEO & Exec. Director)

Mr. Ian Ying Woo (CFO, Pres & Exec. Director)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
100 - 500
Headquarters
New York, New York, United States
Established
2017
Traded as
HKG:1952.HK
Social Media
URL
https://www.everestmedicines.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.
History

Everest Medicines was founded in 2017 by a team of seasoned life science executives from the Greater China region. The company is backed by leading global life science investors. Everest Medicines is based in Shanghai and has offices in Beijing and Hong Kong.

Mission
Our mission is to develop and commercialize innovative treatments to improve the lives of patients suffering from unmet medical needs in Greater China and internationally.
Vision
We will strive to be the leading biopharmaceutical company in Greater China by delivering high quality and effective medicines to improve patient outcomes.
Key Team

Mr. Neo Xiaofan Zhang (COO & Exec. Director)

Dr. Wei Yang Ph.D. (Chief Scientific Officer)

Dr. Kerry Levan Blanchard M.D., Ph.D. (Advisor)

Ms. Yang Shi (Chief Medical Officer - Oncology/Immunology)

Dr. Zhengying Zhu M.D., Ph.D. (Chief Medical Officer - Internal Medicine)

Ms. Xu Zhu (Chief Medical Officer - Infectious Disease)

Dr. Jason M. Brown Ph.D. (Chief Bus. Officer)

Recognition and Awards
Everest Medicines was awarded the 2018 China Healthcare Venture Investment Award in the Drug Development Category, and is a recipient of the 2018 Red Herring Top 100 Asia Award.
References

https://in.investing.com/equities/everest-medicines-ltd

https://finance.yahoo.com/quote/1952.HK/profile?p=1952.HK

https://www.crunchbase.com/organization/everest-medicines

https://www.everestmedicines.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Everest Medicines
Leadership team

Mr. Wei Fu (Exec. Chairman)

Mr. Yongqing Luo (CEO & Exec. Director)

Mr. Ian Ying Woo (CFO, Pres & Exec. Director)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
100 - 500
Headquarters
New York, New York, United States
Established
2017
Traded as
HKG:1952.HK
Social Media
URL
https://www.everestmedicines.com